We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
AAR Corp
AIR
$5.62B
| $416K | ﹤0.01% |
21,922
-1,532
| -7% | -$39.7K |
|
2302
MACOM Technology Solutions
MTSI
$19B
| $415K | ﹤0.01% |
14,327
-506
| -3% | -$16K |
|
|
SASR
2303
DELISTED
Sandy Spring Bancorp Inc
SASR
| $414K | ﹤0.01% |
15,798
-618
| -4% | -$16.6K |
|
|
AENZ
2304
DELISTED
Aenza S.A.A.
AENZ
| $414K | ﹤0.01% |
34,667
| – | – |
|
2305
ArcBest
ARCB
$3.33B
| $413K | ﹤0.01% |
16,019
-937
| -6% | -$28.2K |
|
|
PBY
2306
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
| $413K | ﹤0.01% |
33,842
-853
| -2% | -$10.1K |
|
2307
CALL
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.42B
| $411K | ﹤0.01% |
+3,900
| New | +$417K |
|
|
2308
PUT
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.42B
| $411K | ﹤0.01% |
+3,900
| New | +$417K |
|
|
OSG
2309
Octave Specialty Group
OSG
$261M
| $409K | ﹤0.01% |
28,253
+5,674
| +25% | +$92K |
|
|
HTLF
2310
DELISTED
Heartland Financial USA, Inc.
HTLF
| $409K | ﹤0.01% |
11,271
+254
| +2% | +$9.34K |
|
|
CONN
2311
DELISTED
Conn's Inc.
CONN
| $409K | ﹤0.01% |
17,007
-618
| -4% | -$20.2K |
|
|
LXK
2312
DELISTED
Lexmark Intl Inc
LXK
| $408K | ﹤0.01% |
14,093
+5,132
| +57% | +$173K |
|
2313
Helios Technologies
HLIO
$2.56B
| $406K | ﹤0.01% |
14,781
-186
| -1% | -$6.1K |
|
|
ADAM
2314
Adamas Trust
ADAM
$783M
| $406K | ﹤0.01% |
18,468
-631
| -3% | -$17.5K |
|
2315
AppFolio
APPF
$6.31B
| $404K | ﹤0.01% |
+23,974
| New | +$388K |
|
|
PGI
2316
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $404K | ﹤0.01% |
29,389
-266,617
| -90% | -$3M |
|
2317
Fabrinet
FN
$16.1B
| $403K | ﹤0.01% |
21,968
-366
| -2% | -$6.91K |
|
2318
Ryder
R
$9.98B
| $403K | ﹤0.01% |
5,437
+4,108
| +309% | +$351K |
|
2319
Ingles Markets
IMKTA
$1.71B
| $401K | ﹤0.01% |
8,389
-61
| -0.7% | -$3K |
|
|
GCI
2320
DELISTED
Gannett Co., Inc
GCI
| $401K | ﹤0.01% |
27,196
+10,415
| +62% | +$136K |
|
|
RAVN
2321
DELISTED
Raven Industries Inc
RAVN
| $400K | ﹤0.01% |
23,590
-732
| -3% | -$13.4K |
|
|
TFCFA
2322
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $400K | ﹤0.01% |
14,831
-4,310,184
| -100% | -$129M |
|
2323
Choice Hotels
CHH
$5.22B
| $397K | ﹤0.01% |
8,325
+3,264
| +64% | +$167K |
|
|
WIN
2324
DELISTED
Windstream Holdings Inc
WIN
| $394K | ﹤0.01% |
12,837
-204
| -2% | -$6.36K |
|
2325
CTS Corp
CTS
$1.85B
| $393K | ﹤0.01% |
21,254
-770
| -3% | -$14.4K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.